Wilmington Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$10.3M Sell
165,220
-2,908
-2% -$174K 0.17% 98
2014
Q1
$9.9M Buy
168,128
+74
+0% +$4.13K 0.17% 98
2013
Q4
$8.57M Buy
168,054
+2,853
+2% +$143K 0.14% 111
2013
Q3
$8.31M Sell
165,201
-10,786
-6% -$565K 0.15% 110
2013
Q2
$8.64M Buy
+175,987
New +$9.58M 0.17% 102

Other funds holding LLY

Wilmington Trust's LLY Position: Q2 2014 in Review

Wilmington Trust reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2014, selling an estimated $174K and leaving 165,220 shares worth $10.3M. The position accounts for 0.17% of the portfolio, ranked #98.

Wilmington Trust first reported a position in LLY in Q2 2013 and has held it in 5 quarters since. 1,029 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

  • Wilmington Trust held 165,220 shares of Eli Lilly worth $10.3M as of Q2 2014.
  • Wilmington Trust sold 2,908 Eli Lilly shares in Q2 2014, an estimated $174K.
  • Eli Lilly made up 0.17% of Wilmington Trust's portfolio in Q2 2014, its #98 holding.
  • Wilmington Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 5 quarters since.
  • 1,029 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.